Prescription Drug Abuse Screening & Pain Management Plan Training Simulation

处方药滥用筛查

基本信息

批准号：
7999799
负责人：
Dale Edward Olsen
金额：
$ 48.69万
依托单位：
SIMMERSION, LLC.
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-01-15 至 2012-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7999799
关键词：
Academy Address American American College of Physicians American Society of Clinical Oncology Analgesics Behavior Cessation of life Climacteric Clinical Competence Control Groups Detection Development Drug Prescriptions Drug abuse Education Educational Materials Educational process of instructing Ensure Exercise Family Practice Frequencies Geriatrics Grant Health Health Personnel Health Professional Health Sciences Healthcare Human Intervention Knowledge Laboratories Lead Measures Medical Medical Records Medicine Methods Monitor Nurse Practitioners Nurses Opioid Outcome Pain Pain management Palliative Medicine Paper Participant Patients Pharmacists Phase Physician Assistants Physicians Play Policy Maker Preclinical Drug Evaluation Primary Care Physician Primary Health Care Process Provider Randomized Recruitment Activity Research Risk Role Screening procedure Series Simulate Small Business Innovation Research Grant Societies Stress Students Substance Abuse Detection System Technology Testing Time Toxicology Training Training Programs Universities Visit Wisconsin Work addiction advanced simulation chronic pain computerized efficacy testing experience follow-up high risk hospice environment improved information gathering innovation innovative technologies medical schools misuse of prescription only drugs opioid abuse opioid misuse prescription drug abuse prescription opioid primary care setting programs prototype public health relevance simulation skills success treatment planning virtual

项目摘要

DESCRIPTION (provided by applicant): Prescription drug abuse is a growing concern for several reasons. The practice of obtaining multiple prescriptions and early refills poses a number of health risks for patients who use prescription drugs; because multiple prescriptions or early refills are not closely monitored, it is sometimes up to the primary care physician to properly screen for signs of potential prescription drug abuse and addiction. Clinicians in primary care settings should be equipped with the knowledge to recognize the signs of potential abuse, as well as the steps necessary to address patients who are deemed to be addicted to, or abusing, prescription drugs. The interaction can be difficult, because many patients are either unaware of or evasive about their addiction or abuse. Providing simulation training to help prepare clinicians to better screen patients for potential prescription drug abuse and to identify treatment methods to help these high-risk patients deal with their chronic pain would be very effective. For the Phase II application, SIMmersion LLC, in cooperation with Dr. Michael Fleming of the University of Wisconsin, proposes to develop and evaluate a full-featured interactive simulation to train clinicians in primary care settings how to screen for prescription drug misuse and apply pain management plans. The proposed training simulation will allow physicians and other primary healthcare practitioners to practice the detection and management of prescription opioid misuse in patients suffering from chronic pain. The ideal outcome would be that clinicians become more proficient and comfortable with these skills, and therefore more likely to use them as a routine part of their practice with all patients, thereby reducing the number of people being harmed by the misuse of prescription drugs. To evaluate the efficacy of the simulation training system, Dr. Fleming and his research team will conduct an educational trial. One hundred students and practitioners will be randomly assigned to usual education on prescription drug abuse and misuse (n=50) or to the SIMmersion training program (n=50). Subjects will complete baseline and 6-month post-measures of knowledge and clinical behavior. The measures will include a knowledge pencil-and-paper test and standardized patients. The research will be conducted at the UW Health Sciences Clinical Teaching and Assessment Center. The simulated patient program, using the SIMmersion technology, is expected to significantly advance our ability to train medical professionals in human processing and interaction skills. We expect the end result of the SBIR grant will include improved skills among healthcare professionals in prescription drug screening and application of pain management plans, as well as improved patient outcomes for those who use prescription drugs to manage chronic pain. PUBLIC HEALTH RELEVANCE: Innovative and economical technologies that assist primary care clinicians in acquiring competence in screening patients for prescription drug abuse and chronic pain management could help increase the frequency and efficacy of screening for potential abuse. Screening patients for prescription drug abuse in primary care settings and implementing treatment management plans may help identify abuse sooner and lead to life-changing interventions, which could reduce the negative impact of prescription and other drug abuse and addiction.

描述（由申请人提供）：出于多种原因，处方药滥用日益受到关注。获得多个处方和提前续药的做法给使用处方药的患者带来了许多健康风险；由于多次处方或早期续药没有受到密切监控，有时需要初级保健医生正确筛查潜在处方药滥用和成瘾的迹象。初级保健机构的临床医生应具备识别潜在滥用迹象的知识，以及处理被认为对处方药成瘾或滥用的患者的必要步骤。这种互动可能很困难，因为许多患者要么不知道，要么回避自己的成瘾或滥用行为。提供模拟培训以帮助临床医生更好地筛查患者潜在的处方药滥用情况并确定治疗方法来帮助这些高危患者应对慢性疼痛将是非常有效的。对于第二阶段的应用，SIMmersion LLC 与威斯康星大学的 Michael Fleming 博士合作，提议开发和评估功能齐全的交互式模拟，以培训初级保健机构的临床医生如何筛查处方药滥用和施加疼痛管理计划。拟议的培训模拟将使医生和其他初级保健从业者能够练习检测和管理患有慢性疼痛的患者处方阿片类药物的滥用。理想的结果是临床医生对这些技能变得更加熟练和自如，因此更有可能将它们作为对所有患者进行治疗的常规部分，从而减少因滥用处方药而受到伤害的人数。为了评估模拟训练系统的功效，弗莱明博士和他的研究团队将进行一项教育试验。一百名学生和从业人员将被随机分配到有关处方药滥用和误用的常规教育 (n=50) 或 SIMmersion 培训计划 (n=50)。受试者将完成基线和 6 个月后的知识和临床行为测量。这些措施将包括纸笔知识测试和标准化患者。该研究将在华盛顿大学健康科学临床教学和评估中心进行。使用 SIMmersion 技术的模拟患者程序预计将显着提高我们培训医疗专业人员的人类处理和交互技能的能力。我们预计 SBIR 拨款的最终结果将包括提高医疗保健专业人员在处方药筛查和疼痛管理计划应用方面的技能，以及改善使用处方药治疗慢性疼痛的患者的治疗效果。公共卫生相关性：帮助初级保健临床医生获得筛查患者处方药滥用和慢性疼痛管理能力的创新且经济的技术，有助于提高潜在滥用筛查的频率和有效性。在初级保健机构中筛查患者是否滥用处方药并实施治疗管理计划可能有助于更快地发现滥用情况并导致改变生活的干预措施，从而减少处方药和其他药物滥用和成瘾的负面影响。